荃银高科(300087) - 2021 Q3 - 季度财报

Financial Performance - The company's revenue for Q3 2021 reached ¥521,490,868.06, representing a 61.22% increase year-over-year[4] - Net profit attributable to shareholders was ¥8,507,634.37, a significant increase of 272.08% compared to the same period last year[4] - The basic earnings per share for Q3 2021 was ¥0.0202, a 302.00% increase compared to the same period last year[4] - The company achieved operating revenue of 1,199.17 million RMB in 2021, representing a growth of 35.49% compared to the same period last year[24] - The net profit attributable to shareholders of the listed company was -0.96 million RMB, a decrease of 118.73% year-on-year[24] - The company's net profit for the period was a loss of ¥5,287,574.46, compared to a loss of ¥7,386,397.95 in the previous period, showing an improvement of approximately 28.4%[39] Cash Flow - The net cash flow from operating activities for the year-to-date period was ¥482,912,394.58, showing a remarkable increase of 676.14%[4] - Cash inflow from operating activities totaled 1,870.09 million RMB, an increase of 45.23% due to higher cash receipts from sales[15] - Cash outflow from operating activities was 1,387.18 million RMB, a slight increase of 1.14% attributed to higher payments for goods[15] - The net cash flow from operating activities was 482.91 million RMB, a significant increase of 676.14% compared to the previous year[15] - The cash inflow from financing activities increased by 149.28% to 1,599.19 million RMB, primarily due to an increase in working capital loans[15] - The cash outflow for purchasing goods and services was 1,147,968,665.97, compared to 1,193,564,651.50 in the previous period[46] Assets and Liabilities - Total assets as of the end of Q3 2021 amounted to ¥3,483,973,293.07, reflecting a 40.91% increase from the end of the previous year[4] - The company's equity attributable to shareholders increased to ¥1,205,995,821.90, up 78.59% from the previous year[4] - The total liabilities increased significantly, with contract liabilities rising by 340.16% to ¥914,317,082.80, driven by increased customer deposits[10] - Total liabilities amounted to ¥2,078,733,067.37, up from ¥1,585,198,775.22, which is an increase of about 31.2%[35] - The company's total current assets reached ¥2.74 billion, up from ¥1.83 billion in the previous year, indicating a year-over-year increase of 49.8%[29] - The company's inventory stood at ¥909.69 million, slightly up from ¥893.16 million, reflecting a 1.8% increase[29] Investments and Financing - The company plans to use up to ¥1.79 billion of idle funds and up to ¥450 million of temporarily idle raised funds to purchase short-term financial products[26] - The company has signed a 15-year lease agreement for property with a transaction amount of ¥2.59 million, enhancing its operational capacity[26] - The company completed a private placement of 23,768,366 shares at a price of ¥23.14 per share, raising a net amount of approximately ¥536.92 million after expenses[26] - The company has increased its registered capital from ¥10 million to ¥30 million to support the development of its subsidiary, Shanghai Zhongke Quanyin Molecular Breeding Technology Co., Ltd.[26] Research and Development - Research and development expenses for the year-to-date period were ¥38,530,023.83, a 56.14% increase, indicating a commitment to enhancing innovation[11] - Research and development expenses increased to ¥38,530,023.83 from ¥24,676,803.88, reflecting a growth of about 56.1%[39] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 43,054[16] - The largest shareholder, Sinochem Modern Agriculture Co., Ltd., held 20.37% of the shares, totaling 92,520,965 shares[16] Future Plans - The company plans to continue expanding its seed business and increasing order volumes to drive future growth[24] - The company aims to acquire a 60% stake in Xinjiang Jinfengyuan Seed Industry Co., Ltd. for ¥21.3 million, which will become a subsidiary[26]